Dexcom (NSDQ:DXCM) announced today that it received FDA clearance for its Dexcom Partner Web application programming interfaces (APIs).
The San Diego-based company’s Dexcom Partner Web APIs enable invited third-party developers to integrate real-time continuous glucose monitoring (CGM) data into their digital health apps and devices.
Dexcom’s CGM data can be integrated into third-party apps and devices in several ways, allowing users to quickly see all their therapy data in one place and empower them to use the apps they find most beneficial for a more tailored experience.
The platform also enables in-the-moment diabetes management coaching and feedback.
“FDA clearance of our real-time APIs further solidifies Dexcom as the leader in interoperable CGM, giving Dexcom users even more choice in how they view and interact with their glucose data,” Dexcom chief technology officer Jake Leach said in a news release. “The new APIs will help seamlessly integrate the power of real-time Dexcom CGM data into some of the leading diabetes and digital health solutions.”
According to the release, a number of prominent diabetes and digital health companies have received invitations to access the real-time APIs and are currently in the testing and development phase, including Garmin and Teladoc’s Livongo for Diabetes.
“Garmin welcomes the opportunity to bring Dexcom CGM data to runners, cyclists and everyday users who rely on the technology 24/7 to proactively manage their diabetes,” Garmin VP of fitness Joe Schrick said. “We are proud to be part of this integration that will allow users a secondary way to quickly and discreetly view estimated glucose levels and trends right from their smartwatch at any time.”